Nosso grupo organiza mais de 3.000 Séries de conferências Eventos todos os anos nos EUA, Europa e outros países. Ásia com o apoio de mais 1.000 Sociedades e publica mais de 700 Acesso aberto Periódicos que contém mais de 50.000 personalidades eminentes, cientistas de renome como membros do conselho editorial.

Periódicos de acesso aberto ganhando mais leitores e citações
700 periódicos e 15 milhões de leitores Cada periódico está obtendo mais de 25.000 leitores

Indexado em
  • Índice Copérnico
  • Google Scholar
  • Abra o portão J
  • Genâmica JournalSeek
  • PesquisaBíblia
  • Biblioteca de Periódicos Eletrônicos
  • RefSeek
  • Universidade Hamdard
  • EBSCO AZ
  • OCLC – WorldCat
  • Catálogo online SWB
  • Biblioteca Virtual de Biologia (vifabio)
  • Publons
  • Fundação de Genebra para Educação e Pesquisa Médica
  • ICMJE
Compartilhe esta página

Abstrato

Visualizing Metabolic Landscapes in Cancer: MR Imaging Perspectives

Lipoth Jessica

Cancer is a multifaceted disease characterized by diverse metabolic landscapes within tumors. Deciphering these intricate metabolic profiles is essential for improving cancer diagnosis, treatment, and prognosis. Magnetic Resonance (MR) imaging, combined with spectroscopy, has emerged as a powerful and non-invasive tool for visualizing these metabolic landscapes. This abstract explores the fundamental principles and clinical applications of MR imaging in elucidating the metabolic intricacies of cancer. We discuss its capability to depict glucose metabolism, lactate production, tissue pH, and a wide range of metabolites, providing insights into cancer biology. MR imaging not only enables early cancer diagnosis but also facilitates treatment response assessment, personalized medicine, and prognostication. While challenges in spatial and temporal resolution persist, ongoing technological advancements and data integration hold promise for advancing our understanding of cancer metabolism. In conclusion, MR imaging offers unique perspectives on the metabolic complexities of cancer, contributing significantly to the ongoing fight against this disease.